Advertisement
Advertisement
ZTS
ZOETIS INC.
73.54
USDSponsored
-1.81
-2.40%
Aug 12, 16:00 UTC -4
Closed
Pre-Market
73.91
+0.36
+0.50%
ZTS Earnings Reports
Positive Surprise Ratio
ZTS beat 35 of 42 last estimates.
83%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.37B
/$1.61
Implied change from Q2 26 (Revenue/ EPS)
-3.92%
/-13.90%
Implied change from Q3 25 (Revenue/ EPS)
-1.19%
/-5.29%
ZOETIS INC. earnings per share and revenue
On Aug 06, 2026, ZTS reported earnings of 1.87 USD per share (EPS) for Q2 26, missing the estimate of 1.87 USD, resulting in a -0.22% surprise. Revenue reached 2.47 billion, compared to an expected 2.53 billion, with a -2.34% difference. The market reacted with a +3.87% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 1.61 USD, with revenue projected to reach 2.37 billion USD, implying an decrease of -13.90% EPS, and decrease of -3.92% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Harrow, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.34
Surprise
-85.19%
Altimmune, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+14.22%
Silence Therapeutics Plc - ADR
Report Date
Aug 10, 2026 For Q2 26
Estimate
-Actual
-$0.26
Surprise
-
Aquestive Therapeutics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.18
Surprise
-70.78%
Journey Medical Corporation Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.01
Surprise
+56.33%
Heron Therapeutics, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.01
Actual
-$0.03
Surprise
-394.12%
PolyPid Ltd. Ordinary Shares
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.35
Surprise
+9.28%
Talphera, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.06
Actual
-$0.06
Surprise
+11.76%
Vyome Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.10
Surprise
+48.40%
FAQ
What were ZOETIS INC.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, ZOETIS INC. reported EPS of $1.87, missing estimates by -0.22%, and revenue of $2.47B, -2.34% below expectations.
How did the market react to ZOETIS INC.'s Q2 2026 earnings?
The stock price moved up 3.87%, changed from $74.39 before the earnings release to $77.27 the day after.
When is ZOETIS INC. expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for ZOETIS INC.'s next earnings report?
Based on 13
analysts, ZOETIS INC. is expected to report EPS of $1.61 and revenue of $2.37B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement